Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Services » Servicestothe Health Industry
|IQV||IQVIA Holdings, Inc.||-2.85%||259.08||0.0%||$226.36m|
|DGX||Quest Diagnostics, Inc.||-5.07%||148.75||4.7%||$187.29m|
|LH||Laboratory Corp. of America Holdings||-2.25%||285.34||2.4%||$175.30m|
|AMEH||Apollo Medical Holdings, Inc.||-3.18%||93.67||0.0%||$46.25m|
|NRC||National Research Corp.||-1.48%||40.05||0.0%||$1.44m|
|PLX||Protalix Biotherapeutics, Inc.||0.32%||0.94||18.5%||$0.79m|
|QIPT||Quipt Home Medical Corp.||-0.96%||6.22||0.0%||$0.76m|
Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.